by qfrsolutions | Jul 13, 2016 | News
Source: The Wall Street Journal Michael Pearson has sold nearly $100 million of his stock in Valeant Pharmaceuticals International Inc. in the past two weeks, according to securities filings, following his firing as the troubled drugmaker’s chief executive in...
by qfrsolutions | Jul 8, 2016 | News
Source: Galderma, a global leader focused on medical solutions in skin health, today announced that its U.S. affiliate, Galderma Laboratories, L.P. received approval from the U.S. Food and Drug Administration (FDA) for Differin® Gel (adapalene gel 0.1%) as an...
by qfrsolutions | Jul 5, 2016 | News
Source: LEO Pharma has entered a strategic partnership with AstraZeneca for new medicines for atopic dermatitis and psoriasis, major skin diseases with a significant unmet medical need. Under the move, LEO gains a the global licence to AZ’ tralokinumab in skin...
by qfrsolutions | Jun 28, 2016 | News
Source: Teva’s massive agreement to buy Allergan’s generics business continues to ripple its way through the industry. Australia’s Mayne Pharma has scooped up 42 products from the two companies, which are intent on winning antitrust clearance for...
by qfrsolutions | Jun 24, 2016 | News
Source: Business Wire Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net...
by qfrsolutions | Jun 23, 2016 | News
Source: By Zeba Siddiqui MUMBAI (Reuters) – India’s largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said....
